Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dystonia: phenotypes and genotypes.

S B Bressman1

  • 1Beth Israel Medical Center-Phillips Ambulatory Care Center, Department of Neurology, New York, NY 10003, USA. sbressma@bethisraelny.org

Revue Neurologique
|November 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cognitive and Antipsychotic Medication Use in Monoallelic GBA-Related Parkinson Disease.

JIMD reports·2014
Same author

Transcranial sonography and functional imaging in glucocerebrosidase mutation Parkinson disease.

Parkinsonism & related disorders·2012
Same author

Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites.

Neurology·2012
Same author

Gender differences in the IL6 -174G>C and ESR2 1730G>A polymorphisms and the risk of Parkinson's disease.

Neuroscience letters·2011
Same author

Olfactory dysfunction in LRRK2 G2019S mutation carriers.

Neurology·2011
Same author

Gender differences in the risk of familial parkinsonism: beyond LRRK2?

Neuroscience letters·2011
Same journal

Macrophage inclusions in patients undergoing antisense oligonucleotide therapy for ALS or SMA: A retrospective and transversal study.

Revue neurologique·2026
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
See all related articles

Recent advances expand knowledge of primary torsion dystonia and dystonia-plus syndromes. Genetic mutations like DYT1 are key in early-onset dystonia, while other forms involve parkinsonism or myoclonus.

Area of Science:

  • Neurology
  • Genetics
  • Movement Disorders

Background:

  • Dystonia presents clinical and genetic complexity, with recent expansions in understanding primary torsion dystonia and dystonia-plus syndromes.
  • Primary dystonia includes genetic forms (DYT1, DYT6, DYT13), with the DYT1 mutation being prevalent in early-onset cases, particularly in Ashkenazi populations.
  • Dystonia-plus syndromes are characterized by the co-occurrence of parkinsonism or myoclonus.

Purpose of the Study:

  • To review and synthesize current knowledge on the genetic and clinical aspects of primary torsion dystonia and dystonia-plus syndromes.
  • To highlight the genetic underpinnings, including specific mutations and their prevalence in different populations.
  • To discuss the diagnostic challenges and potential future directions in dystonia classification.

Related Experiment Videos

Main Methods:

  • Literature review and synthesis of existing research on dystonia genetics and clinical presentations.
  • Analysis of prevalence data for specific genetic mutations (e.g., DYT1) in various ethnic groups.
  • Discussion of differential diagnoses and emerging classification strategies based on functional markers.

Main Results:

  • The DYT1 mutation is responsible for approximately 80% of early-onset dystonia in Ashkenazi populations and a significant percentage in non-Ashkenazi populations, primarily affecting limbs and trunk.
  • Dopa-responsive dystonia is linked to mutations in GCH1, TH, or 6-PTS genes, and epsilon-sarcoglycan mutations are associated with a subset of myoclonus-dystonia.
  • A large proportion of dystonia cases remain sporadic and unexplained, underscoring the need for further research.

Conclusions:

  • Understanding the genetic basis of dystonia is crucial for accurate diagnosis and potential therapeutic strategies.
  • Phenotypic overlap among dystonia subtypes necessitates the development of new classifications potentially based on functional imaging and markers.
  • Further research, including functional imaging, is essential to elucidate the mechanisms of sporadic dystonia and refine diagnostic approaches.